Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 3Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Toxemia 1Stomach Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Myocarditis 1Muscle Weakness 1Melanoma 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Neuroendocrine 1Carcinoma in Situ 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Oxaliplatin 29Fluorouracil 23Capecitabine 19pembrolizumab 17Nivolumab 17Leucovorin 16Docetaxel 10Paclitaxel 9Drug Therapy 9Cisplatin 9fludarabine 8Trastuzumab 8S 1 (combination) 8Cyclophosphamide 8Specimen Handling 7trastuzumab deruxtecan 6Bevacizumab 6Magnetic Resonance Spectroscopy 5Biopsy 5zolbetuximab 4Irinotecan 4Carboplatin 4zimberelimab 3sintilimab 3olaparib 3fludarabine phosphate 3durvalumab 3atezolizumab 3aldesleukin 3XELOX 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Positron-Emission Tomography × 90 days × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡